Female infertility
Conditions
Interventions
GnRHa:Triptorelin (Dabipramine 0.1mg/ day) will be routinely administered subcutaneously for 14 days after ovulation
GnRHant group:Give Cetrotide 0.25mg/day when about 12 mm of the follicle diameter until HCG trigger day
Sponsors
Reproductive medicine center of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients with low ovarian reserve and young age who received IVF / ICSI treatment in our center; 2. According to the Poseidon 3 subgroup standard, the age of patients was less than 35 years old, and the ovarian reserve was low (AFC < 5 or AMH < 1.2ng / ml); 3. The 1st-3rd IVF / ICSI treatment cycle.
Exclusion criteria
Exclusion criteria: 1. Patients with more than three cycles of ovulation induction; 2. Patients with severe endometriosis; 3. Hydrosalpinx patients; 4. Patients with endometrial adhesions and malformations; 5. Patients with chromosomal abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cumulative live birth rate per started cycle; | — |
Countries
China
Contacts
Public ContactLai Qiaohong
Reproductive medicine center of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology
Outcome results
None listed